Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Crawford, Brett E ^a,b   Garner, Omai B ^a,b   Bishop, Joseph R ^a   Zhang, David Y ^a   Bush, Kevin T ^c   Nigam, Sanjay K ^a,b,c   Esko, Jeffrey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; N ACETYLGLUCOSAMINE N DEACETYLASE N SULFOTRANSFERASE 1; STAT5 PROTEIN; SULFOTRANSFERASE; UNCLASSIFIED DRUG; CRE RECOMBINASE; HEPARITIN SULFOTRANSFERASE; INTEGRASE; SULFUR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME ACTIVATION; FEMALE; LACTATION; MALE; MILK PRODUCTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SEXUAL MATURITY; SULFATION; WILD TYPE; ANIMAL; ENZYMOLOGY; EPITHELIUM CELL; GENE SILENCING; GENE TARGETING; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MORPHOGENESIS; MOUSE MAMMARY TUMOR ONCOVIRUS; PATHOLOGY; STAINING; TRANSPLANTATION; UDDER;

ANIMALIA; MUS;

ANIMALS; EPITHELIAL CELLS; FEMALE; GENE SILENCING; GENE TARGETING; INTEGRASES; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MORPHOGENESIS; STAINING AND LABELING; SULFOTRANSFERASES; SULFUR;

EID: 77955278541     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010691     Document Type: Article

References (76)

1. Hovey RC, Trott JF, Vonderhaar BK (2002) Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 7: 17-38.
2. Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, et al. (2002) IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell 3: 877-887.
3. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, et al. (2000) Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14: 650-654.
4. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, et al. (1999) Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13: 2604-2616.
5. Dunbar ME, Dann P, Brown CW, Van Houton J, Dreyer B, et al. (2001) Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. J Endocrinol 171: 403-416.
6. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, et al. (2005) Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 65: 2296-2302.
7. Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, et al. (2002) Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol 16: 2675-2691.
8. Humphreys RC, Lydon J, O'Malley BW, Rosen JM (1997) Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol 11: 801-811.
9. Joseph H, Gorska AE, Sohn P, Moses HL, Serra R (1999) Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biol Cell 10: 1221-1234.
10. Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, et al. (2001) The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol 238: 133-144.
11. Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, et al. (1999) Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development 126: 5181-5193.
12. Li L, Cleary S, Mandarano MA, Long W, Birchmeier C, et al. (2002) The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene 21: 4900-4907.
13. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, et al. (2003) Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130: 5257-5268.
14. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, et al. (1999) Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
15. Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, et al. (2002) Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129: 53-60.
16. Robinson GW, Hennighausen L (1997) Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124: 2701-2708.
17. Ruan W, Kleinberg DL (1999) Insulin-like growth factor I is essential for terminal end bud formation and ductal orphogenesis during mammary development. Endocrinology 140: 5075-5081.
18. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, et al. (2003) Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci USA 100: 8281-8286.
19. Wiesen JF, Young P, Werb Z, Cunha GR (1999) Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126: 335-344.
20. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE (1997) Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 11: 1766-1781.
21. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, et al. (1995) Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131: 215-226.
22. Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans finetune mammalian physiology. Nature 446: 1030-1037.
23. Delehedde M, Lyon M, Sergeant N, Rahmoune H, Fernig DG (2001) Proteoglycans: pericellular and cell surface multireceptors external stimuli in the mammary gland. J Mammary Gland Biol Neoplasia 6: 253-273.
24. Lander AD, Nie Q, Wan FY (2002) Do morphogen gradients arise by diffusion? Dev Cell 2: 785-796.
25. Yu WH, Woessner JF, Jr. (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275: 4183-4191.
26. Gordon JR, Bernfield MR (1980) The basal lamina of the postnatal mammary epithelium contains glycosaminoglycans in a precise ultrastructural organization. Dev Biol 74: 118-135.
27. Silberstein GB, Daniel CW (1982) Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev Biol 90: 215-222.
28. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, et al. (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. Faseb J 18: 252-263.
29. Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, et al. (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25: 329-332.
30. Liu BY, Kim YC, Leatherberry V, Cowin P, Alexander CM (2003) Mammary gland development requires syndecan-1 to create a beta-catenin/ TCF-responsive mammary epithelial subpopulation. Oncogene 22: 9243-9253.
31. Yu WH, Woessner JF, Jr., McNeish JD, Stamenkovic I (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16: 307-323.
32. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y (1999) Perlecan is essential for cartilage and cephalic development. Nat Genet 23: 354-358.
33. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, et al. (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. JCell Biol 146: 255-264.
34. Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, et al. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 107: 9-14.
35. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Matsuo S, et al. (2001) Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage. Lab Invest 81: 509-516.
36. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Iwase M, et al. (2001) Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem 276: 47483-47488.
37. Zhou Z, Wang J, Cao R, Morita H, Soininen R, et al. (2004) Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 64: 4699-4702.
38. Lin X, Wei G, Shi ZZ, Dryer L, Esko JD, et al. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224: 299-311.
39. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z (2005) Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132: 5055-5068.
40. Fan G, Xiao L, Cheng L, Wang X, Sun B, et al. (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467: 7-11.
41. Grobe K, Inatani M, Pallerla SR, Castagnola J, Yamaguchi Y, et al. (2005) Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132: 3777-3786.
42. Ringvall M, Ledin J, Holmborn K, Van Kuppevelt T, Ellin F, et al. (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking Ndeacetylase/N-sulfotransferase-1. J Biol Chem 275: 25926-25930.
43. Bullock SL, Fletcher JM, Beddington RS, Wilson VA (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12: 1894-1906.
44. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, et al. (2003) Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278: 28363-28366.
45. Merry CLR, Bullock SL, Swan DC, Backen AC, Lyon M, et al. (2001) The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem 276: 35429-35434.
46. Stanford KI, Wang L, Castagnola J, Song D, Bishop JR, et al. (2010) Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285: 286-294.
47. Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, et al. (2004) Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol 272: 310-327.
48. Shah MM, Sakurai H, Sweeney DE, Gallegos TF, Bush KT, et al. (2010) Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching. Dev Biol 339: 354-365.
49. Esko JD, Selleck SB (2002) Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71: 435-471.
50. Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, et al. (2002) Heparan sulfate and development: Differential roles of the N-acetylglucosamine Ndeacetylase/ N-sulfotransferase isozymes. Biochim Biophys Acta Gen Subj 1573: 209-215.
51. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, et al. (1999) Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400: 773-776.
52. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, et al. (1999) Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400: 769-772.
53. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, et al. (1997) Cremediated gene deletion in the mammary gland. Nucleic Acids Res 25 25: 4323-4330.
54. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, et al. (2001) Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10: 545-553.
55. Bai XM, Wei G, Sinha A, Esko JD (1999) Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J Biol Chem 274: 13017-13024.
56. Allen BL, Rapraeger AC (2003) Spatial and temporal expression of heparin sulfate in mouse development regulates FGF and FGF receptor assembly. J Cell Biol 163: 637-648.
57. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, et al. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem 279: 42732-42741.
58. Shively JE, Conrad HE (1976) Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15: 3932-3942.
59. Bame KJ, Esko JD (1989) Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J Biol Chem 264: 8059-8065.
60. Wang L, Fuster M, Sriramarao P, Esko JD (2005) Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6: 902-910.
61. Jackson D, Bresnick J, Rosewell I, Crafton T, Poulsom R, et al. (1997) Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J Cell Sci 110 (Pt 11): 1261-1268.
62. Dono R, Texido G, Dussel R, Ehmke H, Zeller R (1998) Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. Embo J 17: 4213-4225.
63. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C (1998) Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 95: 5672-5677.
64. Paguirigan A, Beebe DJ, Liu B, Alexander C (2006) Mammary stem and progenitor cells: tumour precursors? Eur J Cancer 42: 1225-1236.
65. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
66. Green KA, Streuli CH (2004) Apoptosis regulation in the mammary gland. Cell Mol Life Sci 61: 1867-1883.
67. Patel VN, Rebustini IT, Hoffman MP (2006) Salivary gland branching morphogenesis. Differentiation 74: 349-364.
68. Cardoso WV, Lu J (2006) Regulation of early lung morphogenesis: questions, facts and controversies. Development 133: 1611-1624.
69. Shah MM, Sampogna RV, Sakurai H, Bush KT, Nigam SK (2004) Branching morphogenesis and kidney disease. Development 131: 1449-1462.
70. Thomson AA, Marker PC (2006) Branching morphogenesis in the prostate gland and seminal vesicles. Differentiation 74: 382-392.
71. Pan Y, Carbe C, Powers A, Zhang EE, Esko JD, et al. (2008) Bud specific Nsulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135: 301-310.
72. Pullan SE, Streuli CH (1996) The mammary gland epithelial cell. In: Harris A, ed. Epithelial Cell Culture: Cambridge. pp 97-121.
73. Streuli CH, Edwards GM, Delcommenne M, Whitelaw CB, Burdon TG, et al. (1995) Stat5 as a target for regulation by extracellular matrix. J Biol Chem 270: 21639-21644.
74. Li M, Wagner KU, Furth PA (2000) Transfection of primary mammary epithelial cells by viral and nonviral methods. In: Asch BB, ed. Methods in Mammary Gland Biology and Breast Cancer Research. New York: Kluwer Academic/Plenum Publishers. pp 233-244.
75. Wei G, Bai XM, Gabb MMG, Bame KJ, Koshy TI, et al. (2000) Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants. J Biol Chem 275: 27733-27740.
76. Faraldo MM, Deugnier MA, Thiery JP, Glukhova MA (2001) Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep 2: 431-437.